DRUG

anti-TF ADC

2 hypotheses across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for anti-TF ADC

Glioblastoma 2

Mediator Outcome Score Tier Lit. status Trial
tissue factor microvascular area 0.220 Mid novel signal none
tissue factor glomeruloid vascular proliferation 0.220 Mid novel signal none

Clinical trials

1 registered trial for anti-TF ADC

Source: ClinicalTrials.gov